Doxorubicin pathways: pharmacodynamics and adverse effects

Pharmacogenet Genomics. 2011 Jul;21(7):440-6. doi: 10.1097/FPC.0b013e32833ffb56.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibiotics, Antineoplastic / adverse effects*
  • Antibiotics, Antineoplastic / pharmacology*
  • Doxorubicin / adverse effects*
  • Doxorubicin / pharmacology*
  • Drug Resistance, Neoplasm
  • Humans
  • Intercalating Agents / adverse effects*
  • Intercalating Agents / pharmacology*
  • Pharmacogenetics
  • Phenotype
  • Polymorphism, Genetic

Substances

  • Antibiotics, Antineoplastic
  • Intercalating Agents
  • Doxorubicin